Torrance, CA (March 20, 2008) – Phenomenex Inc., a leading worldwide manufacturer of separation science consumables, introduces a new line of columns for preparative chromatographic purification of synthetic DNA and RNA. The new Clarity Oligo-WAX media delivers high yields and purity coupled with high loading capacity. These new columns can be used in HPLC and […]
CHALFONT ST. GILES, England and MAIDSTONE, England, Feb. 4, 2008–GE Healthcare, a unit of General Electric Company (NYSE:GE), and Whatman plc (LSE:WHM) announced today that they have reached agreement on the terms of a recommended acquisition of Whatman by GE Healthcare. Under the terms of the transaction, each Whatman shareholder will receive 270 pence in […]
HOLLISTON, Mass.–Harvard Bioscience, Inc. (NASDAQ: HBIO – News) today announced it has completed the sale of its Genomic Solutions Division and its Belgian subsidiary, Maia Scientific, both part of its Capital Equipment Business Segment, to Digilab, Inc. The purchase price payable by Digilab under the terms of the Asset Purchase Agreement consists of $1,000,000 in […]
Chip array key technology with exclusive usage rights expands bio solutions portfolio. Initial systems already on the market. Jena/Itzehoe, November 06, 2007 – Analytik Jena AG (Frankfurt, Prime Standard: AJA), the leading provider of analytical measuring systems for food inspection, environmental analysis, medicine and biotechnology, today announced the conclusion of an agreement which gives Analytik […]
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has acquired NanoDrop Technologies, LLC, a leading manufacturer of micro-volume ultraviolet visible (UV-Vis) instrumentation. The acquisition will strengthen Thermo Fisher’s portfolio of UV-Vis spectrophotometry instruments for applications involving small sample volumes. For example, micro-volume samples are used in emerging life […]
Creating Market and Technology Leader in Molecular Diagnostics Transaction Valued at Approximately US$1.6 Billion Expected to be Accretive in 2008 to QIAGEN’s Earnings Per Share Venlo, The Netherlands and Gaithersburg, Md., USA — June 3, 2007 – QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and Digene Corp. (Nasdaq: DIGE) announced today a definitive agreement […]
Press Release Source: eGene, Inc. QIAGEN Signs Agreement for the Acquisition of eGene Friday April 13, 10:40 am ET Strategic Transaction Adds Capillary Sample Separation Technology VENLO, The Netherlands–QIAGEN N.V. (Nasdaq:QGEN – News; Frankfurt, Prime Standard:QIA), the world’s leading provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics, […]
Roche and CuraGen today announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the agreement, Roche will pay 454 Life Sciences’ shareholders USD 140 million in cash. In addition to the […]
WALTHAM, Mass., Dec. 15 — Thermo Fisher Scientific Inc. (NYSE: TMO – News), the world leader in serving science, today announced it has acquired Massachusetts-based Cohesive Technologies Inc., a manufacturer of advanced sample extraction and liquid chromatography products. Cohesive has annual revenues of approximately $15 million. The Cohesive product line enhances the company’s Thermo Scientific-branded […]
VENLO, The Netherlands, October 30, 2006 – QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the world’s premier supplier of solutions for preanalytical sample preparation, today announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. (Genaco). Genaco is an early-stage company applying a proprietary […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
